Thiriet M. Cardiovascular disease: an introduction. In: Vasculopathies: behavioral, chemical, environmental, and genetic factors. Cham: Springer International Publishing; 2018: 1–90.
Varna M, Calin M, Gebeshuber IC. Advances in Natural and Bio-Inspired Nanoparticles for the Treatment of Cardiovascular Diseases. Nanomaterials (Basel, Switzerland). 2023;13(23).
Klancik V, Kočka V, Sulzenko J, Widimsky P. The many roles of urgent catheter interventions: from myocardial infarction to acute stroke and pulmonary embolism. Expert Rev Cardiovasc Ther. 2023;21(2):123–32.
Carra MC, Rangé H, Caligiuri G, Bouchard P. Periodontitis and atherosclerotic cardiovascular disease: a critical appraisal. Periodontology 2000. 2023.
Zhou M, Zhao G, Zeng Y, Zhu J, Cheng F, Liang W. Aging and cardiovascular disease: current status and challenges. Rev Cardiovasc Med. 2022;23(4):135.
Krupa-Kotara K, Grajek M, Wypych-Ślusarska A, Martynus-Depta S, Oleksiuk K, Głogowska-Ligus J, Szczepańska E, Słowiński J. Properties of polyunsaturated fatty acids in primary and secondary prevention of cardiovascular diseases in the view of patients (Silesia, Poland). Nurs Rep (Pavia Italy). 2022;12(4):980–92.
Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, Brauer M, Kutty VR, Gupta R, Wielgosz A, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet (London England). 2020;395(10226):795–808.
Dasgupta I, Zac-Varghese S, Chaudhry K, McCafferty K, Winocour P, Chowdhury TA, Bellary S, Goldet G, Wahba M, De P, et al. Current management of chronic kidney disease in type-2 diabetes-A tiered approach: an overview of the joint association of British clinical diabetologists and UK kidney association (ABCD-UKKA) guidelines. Diabet Medicine: J Br Diabet Association. 2025;42(2):e15450.
Geng T, Xu W, Gao H, Zhang J, Zou J, Wang K, Li J, Guo L, Wang G, Chen S, et al. Relationship between control of cardiovascular risk factors and chronic kidney disease Progression, cardiovascular disease Events, and mortality in Chinese adults. J Am Coll Cardiol. 2024;84(14):1313–24.
Zou S, Zhang Y, He X, Cheng J, Wang S, Xiong Y, Peng Z, Ao X, Yuan Q. Mortality among individuals with chronic kidney disease based on the 2012 and 2021 KDIGO blood pressure targets. Sci Rep. 2025;15(1):13494.
Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122.
Papaetis GS, Sacharidou A, Michaelides IC, Mikellidis KC, Karvounaris SA. Insulin Resistance, hyperinsulinemia and atherosclerosis: insights into pathophysiological aspects and future therapeutic prospects. Curr Cardiol Rev. 2025;21(1):e1573403X1314035.
Armutcu F, McCloskey E. Insulin resistance, bone health, and fracture risk. osteoporosis international: a journal established as result of Cooperation between the European foundation for osteoporosis and the National osteoporosis foundation of the USA. 2024;35(11):1909–17.
Sun X, Wu Z, Guo D, Chen S, Song C, Ran X, Liu L, Zhang Y, Liu X, Cao G, et al. Triglyceride-glucose index as a superior marker of insulin resistance for predicting long-term major adverse cardiovascular events following coronary artery bypass grafting in China. Sci Rep. 2025;15(1):6450.
Sun Y, Ji H, Sun W, An X, Lian F. Triglyceride glucose (TyG) index: A promising biomarker for diagnosis and treatment of different diseases. Eur J Intern Med. 2025;131:3–14.
Fang Y, Shen J, Lyu L. Value of the triglyceride-glucose index and related parameters in heart failure patients. Front Cardiovasc Med. 2024;11:1397907.
Oliveira PWC, Mill JG, Santos IS, Lotufo PA, Molina M, Mendes FD, Santos HCD, de Faria CP. Triglyceride-glucose index demonstrates reasonable performance as a screening tool but exhibits limited diagnostic utility for insulin resistance: data from the ELSA-Brasil cohort. Nutr Res (New York NY). 2024;124:65–72.
Nakamura Y, Kulkarni NN, Takahashi T, Alimohamadi H, Dokoshi T, Liu E, Shia M, Numata T, Luo EW, Gombart AF, et al. Increased LL37 in psoriasis and other inflammatory disorders promotes LDL uptake and atherosclerosis. J Clin Investig. 2024;134(5).
Biagini D, Ghimenti S, Lenzi A, Bonini A, Vivaldi F, Oger C, Galano JM, Balas L, Durand T, Salvo P, et al. Salivary lipid mediators: key indexes of inflammation regulation in heart failure disease. Free Radic Biol Med. 2023;201:55–65.
Zhao X, Gao C, Chen H, Chen X, Liu T, Gu D. C-Reactive protein: an important inflammatory marker of coronary atherosclerotic disease. Angiology. 2024:33197241273360.
Schulz S, Rehm S, Schlitt A, Lierath M, Lüdike H, Hofmann B, Bitter K, Reichert S. C-Reactive protein level and the genetic variant rs1130864 in the CRP gene as prognostic factors for 10-Year cardiovascular outcome. Cells. 2023;12(13).
Yu W, Liu Z, La Y, Feng C, Yu B, Wang Q, Liu M, Li Z, Feng Y, Ciren L, et al. Associations between residential greenness and the predicted 10-year risk for atherosclerosis cardiovascular disease among Chinese adults. Sci Total Environ. 2023;868:161643.
Feng G, Yang M, Xu L, Liu Y, Yu J, Zang Y, Shen S, Zheng X. Combined effects of high sensitivity C-reactive protein and triglyceride-glucose index on risk of cardiovascular disease among middle-aged and older chinese: evidence from the China health and retirement longitudinal study. Nutr Metabolism Cardiovasc Diseases: NMCD. 2023;33(6):1245–53.
Ruan GT, Xie HL, Zhang HY, Liu CA, Ge YZ, Zhang Q, Wang ZW, Zhang X, Tang M, Song MM, et al. A novel inflammation and insulin resistance related indicator to predict the survival of patients with cancer. Front Endocrinol. 2022;13:905266.
Huo G, Tang Y, Liu Z, Cao J, Yao Z, Zhou D. Association between C-reactive protein-triglyceride glucose index and stroke risk in different glycemic status: insights from the China health and retirement longitudinal study (CHARLS). Cardiovasc Diabetol. 2025;24(1):142.
Ale L, Gentleman R, Sonmez TF, Sarkar D, Endres C. nhanesA: achieving transparency and reproducibility in NHANES research. Database: J Biol Databases Curation. 2024;2024.
Johnson AF, Lamontagne N, Bhupathiraju SN, Brown AG, Eicher-Miller HA, Fulgoni VL 3rd, Rehm CD, Tucker KL, Woteki CE, Ohlhorst SD. Workshop summary: Building an NHANES for the future. Am J Clin Nutr. 2024;119(4):1075–81.
Luo J, Zhu P, Zhou S. Association between the red blood cell distribution width-to-albumin ratio and risk of colorectal and gastric cancers: a cross-sectional study using NHANES 2005–2018. BMC Gastroenterol. 2025;25(1):316.
Qiu X, Wu Q, Zhang Y, Zhu Y, Yang M, Tao L. Association between life’s essential 8 and frailty status among cancer survivors in the united states: a cross-sectional analysis. BMC Public Health. 2024;24(1):1287.
Dang K, Wang X, Hu J, Zhang Y, Cheng L, Qi X, Liu L, Ming Z, Tao X, Li Y. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003–2018. Cardiovasc Diabetol. 2024;23(1):8.
Di Raimondo D, Buscemi S, Musiari G, Rizzo G, Pirera E, Corleo D, Pinto A, Tuttolomondo A. Ketogenic diet, physical activity, and hypertension-A narrative review. Nutrients. 2021;13(8).
Duong KNC, Tan CJ, Rattanasiri S, Thakkinstian A, Anothaisintawee T, Chaiyakunapruk N. Comparison of diagnostic accuracy for diabetes diagnosis: A systematic review and network meta-analysis. Front Med. 2023;10:1016381.
Xu B, Wu Q, La R, Lu L, Abdu FA, Yin G, Zhang W, Ding W, Ling Y, He Z, et al. Is systemic inflammation a missing link between cardiometabolic index with mortality? Evidence from a large population-based study. Cardiovasc Diabetol. 2024;23(1):212.
Pintos-Rodríguez S, Jiménez Díaz VA, Veiga C, Martínez García C, Caamaño Isorna F, Íñiguez Romo A, Juan-Salvadores P. Coronary artery disease in very young women: risk factors and prognostic insights from extended follow-up. J Cardiovasc Dev Disease. 2025;12(2).
Zaheen M, Pender P, Dang QM, Sinha E, Chong JJH, Chow CK, Zaman S. Myocardial infarction in the young: Aetiology, emerging risk factors, and the role of novel biomarkers. J Cardiovasc Dev Disease. 2025;12(4).
Tanaka A, Node K. Associations of metabolic disorders with hypertension and cardiovascular disease: recent findings and therapeutic perspectives. Hypertens Res. 2024;47(12):3338–44.
Zhang Z, Tan L. Association of insulin resistance-related indicators with cardiovascular disease in Chinese people with different glycemic States. Front Endocrinol. 2025;16:1515559.
Liang M, Li WK, Xie XX, Lai BC, Zhao JJ, Yu KW, Ke PF, Wang YX, Kang CM, Huang XZ. OAS1 induces endothelial dysfunction and promotes monocyte adhesion through the NFκB pathway in atherosclerosis. Arch Biochem Biophys. 2025;763:110222.
Horton WB, Love KM, Gregory JM, Liu Z, Barrett EJ. Metabolic and vascular insulin resistance: partners in the pathogenesis of cardiovascular disease in diabetes. Am J Physiol Heart Circ Physiol. 2025.
Kosmas CE, Bousvarou MD, Kostara CE, Papakonstantinou EJ, Salamou E, Guzman E. Insulin resistance and cardiovascular disease. J Int Med Res. 2023;51(3):3000605231164548.
Anderson KC, Liu J, Liu Z. Interplay of fatty acids, insulin and exercise in vascular health. Lipids Health Dis. 2025;24(1):4.
Kirkgöz K. C-Reactive protein in Atherosclerosis-More than a Biomarker, but not just a culprit. Rev Cardiovasc Med. 2023;24(10):297.
Kuppa A, Tripathi H, Al-Darraji A, Tarhuni WM, Abdel-Latif A. C-Reactive protein levels and risk of cardiovascular diseases: A Two-Sample bidirectional Mendelian randomization study. Int J Mol Sci 2023, 24(11).
Satapathy T, Minj A, Verma M. Impact of NSAIDs corticosteroids DMARDs biologics and their comparisons with natural products in C-reactive proteins (CRP) linked cardiovascular disorders. Inflammopharmacology. 2025.
Olson ME, Hornick MG, Stefanski A, Albanna HR, Gjoni A, Hall GD, Hart PC, Rajab IM, Potempa LA. A biofunctional review of C-reactive protein (CRP) as a mediator of inflammatory and immune responses: differentiating pentameric and modified CRP isoform effects. Front Immunol. 2023;14:1264383.
Berbudi A, Khairani S, Tjahjadi AI. Interplay between insulin resistance and immune dysregulation in type 2 diabetes mellitus: implications for therapeutic interventions. ImmunoTargets Therapy. 2025;14:359–82.
Ponce-Lopez T. Peripheral inflammation and insulin resistance: their impact on blood–brain barrier integrity and glia activation in Alzheimer’s disease. Int J Mol Sci. 2025;26.